ABVC Biopharma, a clinical stage biopharmaceutical company announced that BioKey, a wholly-owned subsidiary based in Fremont, California, received an approval of Maitake Mushroom Dietary Supplement Tablet from Taiwan Ministry of Health and Welfare (MHW). This approval served as an Import License (IL) for the shipment of Maitake Mushroom Tablets, which have been developed and manufactured by BioKey for commercial sales in Taiwan under the brand name "DFN." BioKey is currently producing dietary supplements derived from the Maitake Mushroom in tablet and liquid forms.
The company has entered into a three-year distribution agreement with Define Biotech Company, with Define Biotech granted exclusive rights to distribute DFN in China and Taiwan, Shipment of the first bulk lot of Maitake Mushroom Tablets to Define Biotech is in progress for the commercial launch in Taiwan. Define Biotech is a Taiwan-based pharmaceutical marketing company that focuses on sales of drugs, dietary supplements, and medical products in the Asia-Pacific region.
BioKey will manufacture the supplements in a humid, temperature-controlled environment free of pesticides and chemicals at its cGMP Manufacturing facility in Fremont, California.